Revolutionary Cancer Treatment: AI Discovers Personalized Drug Combinations
DeepMind's AlphaFold 3 identifies optimal drug combinations for individual cancer patients based on their genetic profile, leading to 80% higher remission rates in clinical trials.
Blue Origin's Space Hotel Welcomes First Tourists
Jeff Bezos' Blue Origin opens the first commercial space hotel in low Earth orbit, offering 10-day stays with spectacular views of Earth for $1 million per person.


